ABSTRACT
A Belgian traveller was diagnosed with human African trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense nine days after visiting the Masai Mara area in Kenya. He presented with an inoculation chancre and was treated with suramin within four days of fever onset. Two weeks earlier, HAT was also reported in a German traveller who had visited the Masai Mara area. Because no cases have occurred in the area for over 12 years, this may indicate a focal cluster of HAT.
Subject(s)
Travel , Trypanosoma brucei rhodesiense/isolation & purification , Trypanosomiasis, African/diagnosis , Belgium , Chancre/etiology , Fever/etiology , Headache/etiology , Humans , Kenya , Male , Polymerase Chain Reaction/methods , Suramin/therapeutic use , Treatment Outcome , Trypanocidal Agents/therapeutic use , Trypanosoma brucei rhodesiense/genetics , Trypanosomiasis, African/blood , Trypanosomiasis, African/cerebrospinal fluid , Trypanosomiasis, African/drug therapy , White PeopleABSTRACT
The behaviour of 10 probiotic cultures (L. acidophilus, Bifidobacterium sp., L. rhamnosus and L. paracasei) was examined during the production and ripening of Gouda cheese and Camembert. The overall objective of this research project was to obtain a product (cheese) containing at least 10(7) probiotic cfu/g. In general 10(6) cfu of a probiotic culture must be implemented per ml cheese milk, together with the cheesestarter, to reach this objective. L. paracasei sp. have the ability to grow more than 2 log units during cheese ripening. A lower inoculation value can be considered for these cultures.